Cargando…
Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary byp...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149498/ https://www.ncbi.nlm.nih.gov/pubmed/25171167 http://dx.doi.org/10.1371/journal.pone.0105759 |
_version_ | 1782332768647118848 |
---|---|
author | Kahli, Abdelkader Guenancia, Charles Zeller, Marianne Grosjean, Sandrine Stamboul, Karim Rochette, Luc Girard, Claude Vergely, Catherine |
author_facet | Kahli, Abdelkader Guenancia, Charles Zeller, Marianne Grosjean, Sandrine Stamboul, Karim Rochette, Luc Girard, Claude Vergely, Catherine |
author_sort | Kahli, Abdelkader |
collection | PubMed |
description | OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary bypass (CPB). METHODS: Five arterial blood samples were taken sequentially in 34 patients from anesthesia induction (IND) until 24 h after arrival at the intensive care unit (ICU). Plasma levels of GDF-15, follistatin-like 1 (FLST1), myeloperoxidases (MPO), hydroperoxides and plasma antioxidant status (PAS) were measured at each time-point. Markers of cardiac (cardiac-troponin I, cTnI) and renal dysfunction (neutrophil gelatinase-associated lipocalin, NGAL) and other classical biological factors and clinical data were measured. RESULTS: Plasma GDF-15 levels increased gradually during and after surgery, reaching nearly three times the IND levels in the ICU (3,075±284 ng/L vs. 1,061±90 ng/L, p<0.001). Plasma MPO levels increased dramatically during surgery, attaining their highest level after unclamping (UNCLAMP) (49±11 ng/mL vs. 1,679±153 ng/mL, p<0.001) while PAS significantly decreased between IND and UNCLAMP (p<0.05), confirming the high oxidative status induced by this surgical procedure. ICU levels of GDF-15 correlated positively with cTnI and NGAL (p = 0.006 and p = 0.036, respectively), and also with hemoglobin and estimated glomerular filtration rate (eGFR). Among all the post-operative biomarkers available, only eGFR, NGAL and GDF-15 measured at ICU arrival were significantly associated with the onset of acute kidney injury (AKI). Patients with a EuroSCORE >3 were shown to have higher GDF-15 levels. CONCLUSIONS: During cardiac surgery associated with CPB, GDF-15 levels increased substantially and were associated with markers of cardiac injury and renal dysfunction. |
format | Online Article Text |
id | pubmed-4149498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41494982014-09-03 Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass Kahli, Abdelkader Guenancia, Charles Zeller, Marianne Grosjean, Sandrine Stamboul, Karim Rochette, Luc Girard, Claude Vergely, Catherine PLoS One Research Article OBJECTIVE: Growth differentiation factor-15 (GDF-15) has been identified as a strong marker of cardiovascular disease; however, no data are available concerning the role of GDF-15 in the occurrence of organ dysfunction during coronary artery bypass grafting (CABG) associated with cardiopulmonary bypass (CPB). METHODS: Five arterial blood samples were taken sequentially in 34 patients from anesthesia induction (IND) until 24 h after arrival at the intensive care unit (ICU). Plasma levels of GDF-15, follistatin-like 1 (FLST1), myeloperoxidases (MPO), hydroperoxides and plasma antioxidant status (PAS) were measured at each time-point. Markers of cardiac (cardiac-troponin I, cTnI) and renal dysfunction (neutrophil gelatinase-associated lipocalin, NGAL) and other classical biological factors and clinical data were measured. RESULTS: Plasma GDF-15 levels increased gradually during and after surgery, reaching nearly three times the IND levels in the ICU (3,075±284 ng/L vs. 1,061±90 ng/L, p<0.001). Plasma MPO levels increased dramatically during surgery, attaining their highest level after unclamping (UNCLAMP) (49±11 ng/mL vs. 1,679±153 ng/mL, p<0.001) while PAS significantly decreased between IND and UNCLAMP (p<0.05), confirming the high oxidative status induced by this surgical procedure. ICU levels of GDF-15 correlated positively with cTnI and NGAL (p = 0.006 and p = 0.036, respectively), and also with hemoglobin and estimated glomerular filtration rate (eGFR). Among all the post-operative biomarkers available, only eGFR, NGAL and GDF-15 measured at ICU arrival were significantly associated with the onset of acute kidney injury (AKI). Patients with a EuroSCORE >3 were shown to have higher GDF-15 levels. CONCLUSIONS: During cardiac surgery associated with CPB, GDF-15 levels increased substantially and were associated with markers of cardiac injury and renal dysfunction. Public Library of Science 2014-08-29 /pmc/articles/PMC4149498/ /pubmed/25171167 http://dx.doi.org/10.1371/journal.pone.0105759 Text en © 2014 Kahli et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Kahli, Abdelkader Guenancia, Charles Zeller, Marianne Grosjean, Sandrine Stamboul, Karim Rochette, Luc Girard, Claude Vergely, Catherine Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass |
title | Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass |
title_full | Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass |
title_fullStr | Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass |
title_full_unstemmed | Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass |
title_short | Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass |
title_sort | growth differentiation factor-15 (gdf-15) levels are associated with cardiac and renal injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149498/ https://www.ncbi.nlm.nih.gov/pubmed/25171167 http://dx.doi.org/10.1371/journal.pone.0105759 |
work_keys_str_mv | AT kahliabdelkader growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT guenanciacharles growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT zellermarianne growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT grosjeansandrine growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT stamboulkarim growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT rochetteluc growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT girardclaude growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass AT vergelycatherine growthdifferentiationfactor15gdf15levelsareassociatedwithcardiacandrenalinjuryinpatientsundergoingcoronaryarterybypassgraftingwithcardiopulmonarybypass |